ALECT2 amyloidosis

ALECT2 amyloidosis is a rare condition in which an abnormal protein called leukocyte chemotactic factor 2 (LECT2) builds up in organs, especially the kidneys and liver. This protein folds incorrectly and forms clumps called amyloid deposits that gradually damage these organs over time. The disease is also known as ALECT2 amyloid or leukocyte chemotactic factor 2 amyloidosis. It is now recognized as one of the more common types of kidney (renal) amyloidosis in certain populations. The most common way ALECT2 amyloidosis is discovered is when a person develops chronic kidney disease that slowly gets worse. Many patients have protein in their urine and declining kidney function. The liver can also be affected, sometimes showing up as mildly abnormal liver tests or an enlarged liver, though liver involvement often causes no symptoms. Some patients may not have any noticeable symptoms until the disease is fairly advanced. Currently, there is no specific cure or targeted treatment for ALECT2 amyloidosis. Treatment focuses on managing kidney disease and its complications, including controlling blood pressure, reducing protein loss in the urine, and eventually kidney dialysis or transplantation if kidney failure occurs. Research is ongoing to better understand this condition and develop new therapies. Unlike some other forms of amyloidosis, ALECT2 amyloidosis tends to progress slowly, and many patients maintain stable kidney function for years before needing more intensive treatment.

Bring these to your next appointment

• Q1.What stage is my kidney disease, and how quickly is it progressing?,Should my family members be tested for the LECT2 gene variant?,What dietary changes should I make to protect my kidneys?,How often do I need blood and urine tests to monitor my kidney function?,Am I a candidate for kidney transplantation if my kidneys fail?,Are there any clinical trials or new treatments being studied for ALECT2 amyloidosis?,Should I be checked for amyloid deposits in my liver or other organs?

Common questions about ALECT2 amyloidosis